Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis

被引:23
作者
duBouchet, L
Spence, MR
Rein, MF
Danzig, MR
McCormack, WM
机构
[1] SUNY HLTH SCI CTR,DEPT OBSTET & GYNECOL,BROOKLYN,NY 11203
[2] MED COLL PENN & HAHNEMANN UNIV,DIV COMMUNITY HLTH,MED CTR,PHILADELPHIA,PA
[3] UNIV VIRGINIA,HLTH SCI CTR,DEPT MED,CHARLOTTESVILLE,VA
[4] SCHERING PLOUGH CORP,RES INST,KENILWORTH,NJ 07033
关键词
D O I
10.1097/00007435-199703000-00006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: Trichomonas vaginalis is a common vaginal pathogen. Oral metronidazole is the drug of choice for the treatment of trichomoniasis. Oral metronidazole, however, may cause unpleasant side effects and is contraindicated during the first trimester of pregnancy, In vitro studies and preliminary clinical data have suggested that intravaginal clotrimazole may be effective against this pathogen. Goals: To compare the efficacy of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine, and allantoin (AVC suppositories) in the treatment of women with symptomatic trichomoniasis. Study Design: In a multicenter, open-label trial conducted in 1982 and 1983, 168 symptomatic women with microscopically evident vaginal trichomoniasis were randomized to receive any of 2 g of metronidazole as a single oral dose, two 100-mg clotrimazole vaginal tablets once a day for 7 days, or vaginal suppositories containing 1.05 g of sulfanilamide, 14 mg of aminacrine hydrochloride, and 140 mg of allantoin (AVC suppositories) twice a day for 7 days. Wet mounts and cultures were repeated at 1 to 2 and 4 to 6 weeks after completion of treatment. Results: The numbers of patients who had positive cultures after treatment were 40/45 (88.9%) in the clotrimazole group, 35/43 (81.4%) in the AVC suppository group, and 9/45 (20%) in the metronidazole group (P < 0.001), All treatments were associated with a reduction in reported symptoms. Oral metronidazole was more effective in reducing symptoms than either of the topical preparations, Adverse events, mostly mild or moderate in severity, were reported by 7 (14.6%) of 48 patients who had received oral metronidazole and 4 (7.8%) of 51 women who used AVC suppositories, There were no adverse events reported by the 50 women who used clotrimazole vaginal tablets, Conclusions: Oral metronidazole was more effective in eradicating T. vaginalis than clotrimazole vaginal tablets or AVC vaginal suppositories, All three regimens reduced symptoms; oral metronidazole was more effective in reducing symptoms than either topical preparation.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 10 条
[1]  
FORSGREN A, 1979, BRIT J VENER DIS, V55, P351
[2]  
HEYWORTH R, 1980, LANCET, V2, P476
[3]   USE OF A TIME-KILL TECHNIQUE FOR SUSCEPTIBILITY TESTING OF TRICHOMONAS-VAGINALIS [J].
KRIEGER, JN ;
DICKINS, CS ;
REIN, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :332-336
[4]  
LEGAL HP, 1974, POSTGRAD MED J, V50, pS81
[5]  
LOHMEYER H, 1974, POSTGRAD MED J, V50, pS78
[6]   EVALUATION OF 2 SEROLOGICAL TESTS FOR TRICHOMONAS-VAGINALIS INFECTION [J].
MATHEWS, HM ;
HEALY, GR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (05) :840-843
[7]  
MORTON RS, 1972, BRIT J VENER DIS, V48, P525
[8]  
MULLER M, 1980, AM J OBSTET GYNECOL, V138, P808
[9]  
SCHNELL JD, 1974, POSTGRAD MED J, V50, pS79
[10]  
1975, MED LETT DRUGS THERA, V17